Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1986
Connective tissue activation. XXX: Isoelectric point microheterogeneity of CTAP-III, a human platelet-derived growth factorM S Green, P A Hossler, C W Castor
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 10, 1981
Connective tissue activation. XXIII. Increased plasma levels of a platelet growth factor (CTAP-III) in patients with rheumatic diseasesD K MacCarter, P A Hossler, C W Castor
The Journal of Rheumatology|November 1, 1980
Connective tissue activation XIX. Plasma levels of the CTAP-III platelet antigen in rheumatoid arthritisS L Myers, P A Hossler, C W Castor
Antimicrobial Agents and Chemotherapy|August 1, 1995
Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugsY L Hong, P A Hossler, D H Calhoun, et al.
Arthritis and Rheumatism|April 1, 1983
Connective tissue activation. XXV. Regulation of proteoglycan synthesis in human synovial cellsC W Castor, D J Roberts, P A Hossler, et al.
The Journal of Rheumatology|February 7, 1998
Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine networkC W Castor, E M Smith, M C Bignall, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1981
Connective tissue activation. XXII. A platelet growth factor (connective tissue-activating peptide-III) in human growth hormone-deficient patientsC W Castor, S R Cobel-Geard, P A Hossler, et al.
The Journal of Biological Chemistry|September 25, 1992
Regulation of glucose transporters by connective tissue activating peptide-III isoformsP K Tai, J F Liao, P A Hossler, et al.
Pageof 2